| Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference P Wallemacq, VW Armstrong, M Brunet, V Haufroid, DW Holt, A Johnston, ... Therapeutic drug monitoring 31 (2), 139-152, 2009 | 545 | 2009 |
| Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirement IAM Macphee, S Fredericks, T Tai, P Syrris, ND Carter, A Johnston, ... Transplantation 74 (11), 1486-1489, 2002 | 426 | 2002 |
| Therapeutic drug monitoring of immunosuppressant drugs in clinical practice BD Kahan, P Keown, GA Levy, A Johnston Clinical therapeutics 24 (3), 330-350, 2002 | 370 | 2002 |
| Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome: workshop recommendations DC Cattran, E Alexopoulos, P Heering, PF Hoyer, A Johnston, A Meyrier, ... Kidney international 72 (12), 1429-1447, 2007 | 331 | 2007 |
| The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation IAM MacPhee, S Fredericks, T Tai, P Syrris, ND Carter, A Johnston, ... American Journal of Transplantation 4 (6), 914-919, 2004 | 311 | 2004 |
| Substandard drugs: a potential crisis for public health A Johnston, DW Holt British journal of clinical pharmacology 78 (2), 218-243, 2014 | 280 | 2014 |
| Evidence for a difference in nitric oxide biosynthesis between healthy women and men P Forte, BJ Kneale, E Milne, PJ Chowienczyk, A Johnston, N Benjamin, ... Hypertension 32 (4), 730-734, 1998 | 274 | 1998 |
| Tacrolimus pharmacogenetics: the CYP3A5* 1 allele predicts low dose-normalized tacrolimus blood concentrations in whites and South Asians IAM MacPhee, S Fredericks, M Mohamed, M Moreton, ND Carter, ... Transplantation 79 (4), 499-502, 2005 | 261 | 2005 |
| Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2) 1 G Levy, P Burra, A Cavallari, C Duvoux, J Lake, AD Mayer, S Mies, ... Transplantation 73 (6), 953-959, 2002 | 231 | 2002 |
| Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2) 1 G Levy, P Burra, A Cavallari, C Duvoux, J Lake, AD Mayer, S Mies, ... Transplantation 73 (6), 953-959, 2002 | 226 | 2002 |
| Ciclosporin in psoriasis clinical practice: an international consensus statement CEM Griffiths, L Dubertret, CN Ellis, AY Finlay, AF Finzi, VC Ho, ... British journal of dermatology 150 (s67), 11-23, 2004 | 208 | 2004 |
| Consensus document: Hawk's Cay meeting on therapeutic drug monitoring of cyclosporine BD Kahan, LM Shaw, D Holt, J Grevel, A Johnston Clinical chemistry 36 (8), 1510-1516, 1990 | 205 | 1990 |
| Influence of donor C3 allotype on late renal-transplantation outcome KM Brown, E Kondeatis, RW Vaughan, SP Kon, CKT Farmer, JD Taylor, ... New England Journal of Medicine 354 (19), 2014-2023, 2006 | 203 | 2006 |
| Influence of donor C3 allotype on late renal-transplantation outcome KM Brown, E Kondeatis, RW Vaughan, SP Kon, CKT Farmer, JD Taylor, ... New England Journal of Medicine 354 (19), 2014-2023, 2006 | 203 | 2006 |
| Oxidative stress could precede endothelial dysfunction and insulin resistance in Indian Mauritians with impaired glucose metabolism NK Gopaul, MD Manraj, A Hebe, SLK Yan, A Johnston, MJ Carrier, ... Diabetologia 44, 706-712, 2001 | 197 | 2001 |
| Method and apparatus for preventing bacteriological contamination by a dental tool water line SE Johnston, AM Johnston, JF Williams US Patent 5,204,004, 1993 | 178 | 1993 |
| Effect of dose and schedule on pharmacokinetics of high-dose cytosine arabinoside in plasma and cerebrospinal fluid. ML Slevin, EM Piall, GW Aherne, VJ Harvey, A Johnston, TA Lister Journal of Clinical Oncology 1 (9), 546-551, 1983 | 173 | 1983 |
| Construction and application of an evaluative tool to assess reflection in teacher-training courses Z Fund, D Court, B Kramarski Assessment & Evaluation in Higher Education 27 (6), 485-499, 2002 | 157* | 2002 |
| Parmacokinetic validation of neoral absorption profiling A Johnston Transplant Proceedings 32, 53S-56S, 2000 | 148 | 2000 |
| Variable bioavailability of oral melatonin WL Di, A Kadva, A Johnston, R Silman New England Journal of Medicine 336 (14), 1028-1029, 1997 | 148 | 1997 |
David W HoltSt George's University of LondonVerified email at bioanalytics.co.uk
